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OBJECTIVE — Oral leukoplakia is an oral lesion with a premalignant character. Besides
smokingandalcohol,diabetescouldbeariskfactor.Theaimistosearchforsuchanassociation.
RESEARCH DESIGN AND METHODS — Subjects with leukoplakia (N  123) from
the population-based Study of Health in Pomerania (SHIP) were matched 1:2 for age and sex
with unaffected control subjects. Behavioral and lifestyle factors were assessed by a question-
naire. Lipoprotein concentrations, glycemia, and inﬂammation parameters were determined.
RESULTS — Subjects with oral leukoplakia showed higher levels of diabetes-related metab-
olites, a higher LDL/HDL cholesterol ratio (P  0.004), and higher A1C (P  0.002), and they
were more frequently smokers (P  0.001). Assessed by conditional logistic regression, the
probabilityofleukoplakiaincreaseswithcurrentsmoking(oddsratio2.20[95%CI1.16–4.17])
and higher levels of A1C (1.51 [95% CI 1.08–2.12]), revealing interaction between both factors
(P  0.012).
CONCLUSIONS — Diabetes is associated with the risk of oral leukoplakia, which is exag-
gerated by smoking. The risk is positively correlated with A1C concentrations.
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D
iabetes is related to different patho-
logical states in the oral cavity in-
cluding premalignant and
malignant lesions (1–3). Leukoplakia is
an asymptomatic, potentially malignant
lesion in the oral mucosa. Between 1
and 18% of oral premalignant lesions will
developintooralcancer(4).Smokingand
drinking alcohol are main risk factors for
this disease (5). Even though there is a
strong association between diabetes and
leukoplakia, a causal mechanism for that
has not been elucidated. In the present
study, we assess the effect of metabolic
risk factors on oral leukoplakia.
RESEARCH DESIGN AND
METHODS— The Study of Health in
Pomerania(SHIP)isacross-sectionalsur-
vey of the adult population in northeast
Germany. A random sample was drawn
from residents’ registration ofﬁces and
stratiﬁed by sex and age (20–80 years).
Of the eligible individuals, 68.8% (n 
4,310) participated in this study, and
4,210 of them were screened for oral mu-
cosal lesions (6). All participants gave
written informed consent. The study was
approved by the local ethics committee.
Interviews were used to gain information
on anamnestic, behavioral, and socio-
demographic characteristics. Smoking
status was assessed by self-report.
The examination of oral mucosa for
lesions, oral leukoplakia, erythroplakia,
lichen ruber, ulcers, and others covered
all areas of the oral cavity, including the
tongue and lips, and was conducted ac-
cording to the guidelines of the German
Cancer Association (7). Examiners were
trained for consistent diagnostics with
suitable patients and photographic
material.
Glycosylated hemoglobin (A1C), to-
talcholesterol,HDLcholesterol(HDL-C),
LDL cholesterol (LDL-C), plasma ﬁbrino-
gen (using the Clauss method), and white
blood cell count were assayed with stan-
dard laboratory methods, and high-
sensitivity C-reactive protein (hs-CRP)
was assayed by immuno-nephelometry
(Dade Behring, Inc.). For A1C levels, a
threshold of 6.5% was set (8).
A total of 123 case subjects with leu-
koplakia simplex were identiﬁed and a
123:246 case-control study was built,
matched for sex and age. We used the
Mann-WhitneyUtestandcontingenceta-
bles for continuous and categorical vari-
ables, respectively. Leukoplakia was the
dichotomous dependent variable in con-
ditional logistic regression and was ad-
justed for matching variables and
potential confounders. Data analyses
were performed using STATA.
RESULTS— Amongthestudypopula-
tion, 2.9% (n  123) of the patients had
oral leukoplakia. These subjects were
compared with their unaffected, matched
counterpartswithrespecttogeneralchar-
acteristics and clinical chemistry parame-
ters (Table 1). We found signiﬁcant
differences in metabolic parameters char-
acterizingtheglucoseandcholesterolme-
tabolism. Correspondingly, among the
leukoplakia cases, more subjects with
type 2 diabetes were noticed. As ex-
pected, smoking was over-represented in
the cases group. Markers of systemic in-
ﬂammation (hs-CRP, ﬁbrinogen) were
higher in case subjects, and measures re-
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bleeding or attachment loss, were worse
in cases.
In a ﬁrst stratiﬁcation for combined
risks, we found the crude risk of leuko-
plakia was increased in never smokers
with hyperglycemia of A1C 6.5% (OR
2.49 [95% CI 1.05–5.89]) comparable to
the risk of normoglycemic smokers (2.21
[95%CI1.30–3.75]).Forthosewhohave
bothfactorscombined,theriskofbelong-
ing to the leukoplakia group may be even
higher (2.66 [95% CI 1.01–6.95]).
A conditional logistic regression was
performed adjusting for age, former and
current smoking, alcohol consumption,
education,andLDLandHDLcholesterol.
A1Cwassigniﬁcantlyassociatedwithleu-
koplakia, indicating an increase in the
probability of the outcome: A1C OR 1.51
(95% CI 1.08–2.12), thereby exhibiting
signiﬁcantinteractionwithcurrentsmok-
ing(A1Csmoking,P0.012).Innon-
smokers, the leukoplakia probability was
lowatnormoglycemicstate.Buttherewas
a more pronounced increase in the prob-
ability of having leukoplakia with the in-
creasing metabolic factor A1C as
comparedwithsmokers.Smokerswereat
increasedriskevenwhenhavinglowA1C
levels. This was conﬁrmed in an analysis
stratiﬁed by smoking, resulting in odds
ratios associated with A1C: never smok-
ers OR  1.96 (95% CI 1.15–3.37), ever
smokersOR1.29(95%CI0.80–2.09).
Similarly, LDL-C proved to be a risk fac-
tor:inneversmokersOR3.01(95%CI
1.40–6.50), ever smokers OR  1.47
(95% CI 1.00–2.15).
CONCLUSIONS— Smoking and
drinkingalcoholhavelongbeenregarded
as the sole cause in the etiology of prema-
lignantoralmucosalesionssuchasleuko-
plakia (5). However, in the search for
further risk factors, diabetes may also be
associatedwiththeoccurrenceoforalleu-
koplakias as well. In large population
studies,diabeticindividualshavebeenre-
ported to be over-represented in subjects
with oral lesions. In the National Health
and Nutrition Examination Survey III, an
OR of 2 was found, suggesting that di-
abetes is a strong predictor of oral leuko-
plakia (4). Similar ﬁgures were reported
in a study including more than 900 leu-
koplakia cases in women but not in men
(3). We found evidence that diabetes-
related metabolic factors are associated
with the occurrence of leukoplakia most
pronounced in nonsmokers. Smoking
seems to override the metabolic impact.
The smoke-related burden is high even at
lowlevelsofA1CorLDL-C.Chronicmet-
abolic deteriorations may have a similar
inﬂuence on the risk as lifetime exposure
to tobacco smoking expressed as
pack-years.
Results from the logistic regression
suggest that there is a continuously in-
creasingriskwithincreasinglevelsofA1C
or of LDL-C. Accordingly, the risk seems
toberelatedtoquantitativemetabolicdis-
turbances rather than to distinct cases of
diabetes. As in other tissues, the diabetic
metabolism leads to profound deteriora-
tions in the oral cavity that may predis-
pose for oral leukoplakia (9). The
associationofleukoplakiawithincreasing
LDL-C/HDL-C ratios could be explained
by the disturbed lipid metabolism fre-
quently seen in diabetic patients (10).
Premalignant lesions are often associated
with a background of chronic inﬂamma-
tion (11).
Diabetes is one of the main risk fac-
tors, besides smoking, of inﬂammatory
periodontitis (12). The dental parameters
(Table 1) indicate a possible role of local
inﬂammation and may be related to the
risks in common with diabetes (13).
Limitations of this survey are the
missing biopsies for diagnosing the oral
lesionsandnonfastingbloodanalyses.Le-
sions were classiﬁed as clinical diagnoses,
as recommended when biopsies are miss-
ing (14). The cross-sectional study design
precludes causal considerations.
The results ﬁt the hypothesis that ac-
cumulation of carbohydrates contributes
to the risk of preneoplastic lesions (15).
Metabolic disturbances in diabetes with
interactions between systemic and local
factors have manifestations in the oral
cavity.
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Table 1—Characteristics of participants included in the matched-pair analysis with leukopla-
kia (n  123) and control subjects without (n  246), matched for age and sex
Leukoplakia
No
leukoplakia P
Subjects (female/male) (n) 55/68 110/136 §
Age (years) 55.2  15.5 55.2  15.6 §
Smokers
Former (%) 25 (20) 55 (22) 0.389
Current (%) 50 (41) 55 (22) 0.001
Pack-years smoked 13.8  21.1 8.5  14.3 0.002
Alcohol (g/week) 106  154 82  115 0.472
Subjects with type 2 diabetes (%) 27 (22) 31 (13) 0.001
A1C (%) 6.0  1.2 5.6  1.0 0.002
Glucose (mmol/l)* 6.5  2.6 5.8  1.7 0.007
Total cholesterol (mmol/l)* 6.2  1.3 5.7  1.2 0.003
LDL/HDL cholesterol ratio 3.1  1.3 2.6  1.0 0.004
LDL-C (mmol/l)* 3.9  1.2 3.5  1.1 0.008
HDL-C (mmol/l)* 1.4  0.4 1.5  0.4 0.194
WBC count (Tpt/l) 7.1  2.1 6.6  1.9 0.087
hs-CRP (mg/l) 3.4  4.7 3.0  6.0 0.225
Fibrinogen (mg/l) 3.1  0.7 3.0  0.7 0.072
Subjects with visceral obesity (%)† 47 (38) 68 (28) 0.039
Subjects with hypertension (%)† 53 (43) 97 (39) 0.500
Education 10th grade (%) 53 (43) 121 (49) 0.269
Last dental visit 1 year back (%) 34 (28) 45 (18) 0.001
Mean gingival attachment loss (mm) 3.6  2.2 2.9  2.0 0.012
Attachment loss, % of sites 3 (mm) 75 (33–97) 49 (19–89) 0.027
Gingival bleeding on probing, % of sites 46 (25–75) 35 (12–58) 0.010
Edentulous subjects (%) 26 (21) 41 (17) 0.294
Data are means  SD, n (%), median (interquartile range). WBC, white blood cell. §Matching variable,
reference:neversmokers,*nonfasting,†accordingtoNationalCholesterolEducationProgram,AdultTreat-
ment Panel III.
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